Cargando…
Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1
BACKGROUND: Citicoline is one of the neuroprotective agents that have been used as a therapy in stroke patients. There is limited published data describing the mechanisms through which it acts. METHODS: We used in vitro angiogenesis assays: migration, proliferation, differentiation into tube-like st...
Autores principales: | Krupinski, Jerzy, Abudawood, Manal, Matou-Nasri, Sabine, Al-Baradie, Raid, Petcu, Eugen Bogdan, Justicia, Carlos, Planas, Anna, Liu, Donghui, Rovira, Norma, Grau-Slevin, Marta, Secades, Julio, Slevin, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554547/ https://www.ncbi.nlm.nih.gov/pubmed/23227823 http://dx.doi.org/10.1186/2045-824X-4-20 |
Ejemplares similares
-
Role of Citicoline in the Management of Traumatic Brain Injury
por: Secades, Julio J.
Publicado: (2021) -
Targeting p35/Cdk5 Signalling via CIP-Peptide Promotes Angiogenesis in Hypoxia
por: Bosutti, Alessandra, et al.
Publicado: (2013) -
Citicoline: pharmacological and clinical review, 2022
update
por: Secades, Julio J., et al.
Publicado: (2022) -
Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells
por: Fang, Wen-Hui, et al.
Publicado: (2016) -
Emerging Molecular Targets for Brain Repair after Stroke
por: Krupinski, Jerzy, et al.
Publicado: (2013)